<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Clinical Sequencing - Enhanced</title>
    <style>
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body {
            font-family: Aptos, 'Segoe UI', sans-serif;
            background: white;
            display: flex;
            justify-content: center;
            align-items: center;
            min-height: 100vh;
            padding: 40px 20px;
        }
        .container { width: 960px; padding: 35px 45px; }
        .title {
            font-size: 36px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 30px;
            text-align: center;
        }
        .section {
            margin-bottom: 25px;
        }
        .section-title {
            font-size: 22px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 15px;
            padding-bottom: 8px;
            border-bottom: 2px solid #e0e8f4;
        }
        .content-box {
            background: #f8fbff;
            border: 2px solid #1E64C8;
            border-radius: 10px;
            padding: 20px;
            margin-bottom: 15px;
        }
        .bullet-list {
            display: flex;
            flex-direction: column;
            gap: 10px;
        }
        .bullet-item {
            display: flex;
            align-items: flex-start;
            font-size: 17px;
            color: #333;
        }
        .bullet-item::before {
            content: "â€¢";
            color: #1E64C8;
            font-weight: bold;
            margin-right: 12px;
            font-size: 20px;
        }
        .info-grid {
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 20px;
        }
        .info-box {
            background: #f0f5fc;
            border-left: 4px solid #1E64C8;
            padding: 18px 22px;
            border-radius: 6px;
        }
        .info-label {
            font-size: 16px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 8px;
        }
        .info-text {
            font-size: 16px;
            color: #333;
            line-height: 1.6;
        }
        .highlight-box {
            background: #fff4e6;
            border: 2px solid #1E64C8;
            border-radius: 8px;
            padding: 18px 24px;
            text-align: center;
            margin-bottom: 30px;
        }
        .highlight-text {
            font-size: 18px;
            color: #333;
            font-weight: 500;
        }
        .spec-grid {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 15px;
        }
        .spec-box {
            background: #f0f5fc;
            border: 2px solid #1E64C8;
            border-radius: 8px;
            padding: 15px;
            text-align: center;
        }
        .spec-label {
            font-size: 14px;
            color: #666;
            margin-bottom: 5px;
        }
        .spec-value {
            font-size: 18px;
            font-weight: 700;
            color: #1E64C8;
        }
        .example-section {
            margin-top: 40px;
            padding-top: 30px;
            border-top: 3px solid #1E64C8;
        }
        .example-card {
            background: white;
            border: 2px solid #1E64C8;
            border-radius: 12px;
            padding: 25px;
            margin-bottom: 30px;
            box-shadow: 0 4px 6px rgba(0,0,0,0.1);
        }
        .example-title {
            font-size: 20px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 15px;
            display: flex;
            align-items: center;
        }
        .example-number {
            background: #1E64C8;
            color: white;
            width: 32px;
            height: 32px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            margin-right: 12px;
            font-weight: 700;
        }
        .illustration-box {
            background: linear-gradient(135deg, #f0f5fc 0%, #e6f0ff 100%);
            border: 2px dashed #1E64C8;
            border-radius: 10px;
            padding: 30px;
            margin: 20px 0;
            text-align: center;
        }
        .workflow-diagram {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin: 20px 0;
        }
        .workflow-step {
            flex: 1;
            background: white;
            border: 2px solid #1E64C8;
            border-radius: 8px;
            padding: 15px;
            margin: 0 5px;
            text-align: center;
        }
        .workflow-arrow {
            color: #1E64C8;
            font-size: 24px;
            font-weight: bold;
        }
        .example-description {
            font-size: 16px;
            line-height: 1.8;
            color: #333;
            margin-bottom: 15px;
        }
        .detail-box {
            background: #f8fbff;
            border-left: 4px solid #4a9eff;
            padding: 15px 20px;
            margin: 15px 0;
            border-radius: 4px;
        }
        .detail-title {
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 8px;
        }
        .gene-box {
            display: inline-block;
            background: #1E64C8;
            color: white;
            padding: 8px 15px;
            border-radius: 20px;
            margin: 5px;
            font-weight: 600;
            font-size: 14px;
        }
        .variant-display {
            background: #2d2d2d;
            color: #0f0;
            font-family: 'Courier New', monospace;
            padding: 15px;
            border-radius: 6px;
            margin: 15px 0;
            overflow-x: auto;
        }
        .case-example {
            background: #fff9e6;
            border: 2px solid #ffc107;
            border-radius: 8px;
            padding: 18px;
            margin: 15px 0;
        }
        .case-title {
            font-weight: 600;
            color: #f57c00;
            margin-bottom: 10px;
        }
        .stats-grid {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 15px;
            margin: 20px 0;
        }
        .stat-card {
            background: white;
            border: 2px solid #4a9eff;
            border-radius: 8px;
            padding: 15px;
            text-align: center;
        }
        .stat-number {
            font-size: 28px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 5px;
        }
        .stat-label {
            font-size: 14px;
            color: #666;
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="title">Clinical Sequencing</div>
        
        <div class="content-box">
            <div class="section-title">Clinical NGS Applications</div>
            <div class="bullet-list">
                <div class="bullet-item">Diagnosis of rare genetic diseases</div>
                <div class="bullet-item">Cancer precision medicine and treatment selection</div>
                <div class="bullet-item">Pharmacogenomics - drug response prediction</div>
                <div class="bullet-item">Prenatal and newborn screening</div>
                <div class="bullet-item">Infectious disease identification</div>
            </div>
        </div>

        <div class="section">
            <div class="section-title">Clinical Considerations</div>
            <div class="info-grid">
                <div class="info-box">
                    <div class="info-label">Quality Standards</div>
                    <div class="info-text">â€¢ CLIA/CAP certification<br>â€¢ High coverage (>30X)<br>â€¢ Validated pipelines<br>â€¢ Quality control metrics</div>
                </div>
                <div class="info-box">
                    <div class="info-label">Interpretation</div>
                    <div class="info-text">â€¢ ACMG variant classification<br>â€¢ Clinical significance<br>â€¢ Actionable findings<br>â€¢ Secondary findings reporting</div>
                </div>
                <div class="info-box">
                    <div class="info-label">Ethical Issues</div>
                    <div class="info-text">â€¢ Informed consent<br>â€¢ Incidental findings<br>â€¢ Data privacy<br>â€¢ Genetic counseling</div>
                </div>
                <div class="info-box">
                    <div class="info-label">Reimbursement</div>
                    <div class="info-text">â€¢ Insurance coverage<br>â€¢ CPT codes<br>â€¢ Medical necessity<br>â€¢ Prior authorization</div>
                </div>
            </div>
        </div>

        <div class="highlight-box">
            <div class="highlight-text">Requires multidisciplinary team: clinicians, geneticists, bioinformaticians, counselors</div>
        </div>

        <!-- DETAILED EXAMPLES SECTION -->
        <div class="example-section">
            <div class="section-title" style="font-size: 28px; text-align: center; margin-bottom: 30px;">Detailed Clinical Applications & Examples</div>

            <!-- Example 1: Rare Genetic Diseases -->
            <div class="example-card">
                <div class="example-title">
                    <span class="example-number">1</span>
                    Diagnosis of Rare Genetic Diseases
                </div>
                
                <div class="example-description">
                    Whole Exome Sequencing (WES) and Whole Genome Sequencing (WGS) have revolutionized the diagnosis of rare genetic disorders. These technologies enable comprehensive analysis of all protein-coding genes or the entire genome, identifying pathogenic variants that cause disease.
                </div>

                <div class="illustration-box">
                    <div class="workflow-diagram">
                        <div class="workflow-step">
                            <div style="font-size: 24px; margin-bottom: 8px;">ðŸ‘¤</div>
                            <div style="font-weight: 600;">Patient</div>
                            <div style="font-size: 13px; color: #666;">Undiagnosed symptoms</div>
                        </div>
                        <div class="workflow-arrow">â†’</div>
                        <div class="workflow-step">
                            <div style="font-size: 24px; margin-bottom: 8px;">ðŸ§¬</div>
                            <div style="font-weight: 600;">DNA Sample</div>
                            <div style="font-size: 13px; color: #666;">Blood/Saliva</div>
                        </div>
                        <div class="workflow-arrow">â†’</div>
                        <div class="workflow-step">
                            <div style="font-size: 24px; margin-bottom: 8px;">ðŸ”¬</div>
                            <div style="font-weight: 600;">WES/WGS</div>
                            <div style="font-size: 13px; color: #666;">Sequencing</div>
                        </div>
                        <div class="workflow-arrow">â†’</div>
                        <div class="workflow-step">
                            <div style="font-size: 24px; margin-bottom: 8px;">ðŸ’»</div>
                            <div style="font-weight: 600;">Analysis</div>
                            <div style="font-size: 13px; color: #666;">Variant calling</div>
                        </div>
                        <div class="workflow-arrow">â†’</div>
                        <div class="workflow-step">
                            <div style="font-size: 24px; margin-bottom: 8px;">ðŸ“‹</div>
                            <div style="font-weight: 600;">Diagnosis</div>
                            <div style="font-size: 13px; color: #666;">Clinical report</div>
                        </div>
                    </div>
                </div>

                <div class="case-example">
                    <div class="case-title">ðŸ“Œ Clinical Case Example</div>
                    <strong>Patient:</strong> 6-year-old boy with developmental delay, seizures, and intellectual disability<br>
                    <strong>Previous testing:</strong> Karyotype, microarray - negative<br>
                    <strong>WES Result:</strong> De novo pathogenic variant in SCN1A gene<br>
                    <strong>Diagnosis:</strong> Dravet syndrome<br>
                    <strong>Impact:</strong> Changed treatment plan, avoided ineffective/harmful medications, genetic counseling for family
                </div>

                <div class="detail-box">
                    <div class="detail-title">Common Genes Analyzed in Rare Disease Panels</div>
                    <span class="gene-box">SCN1A</span>
                    <span class="gene-box">MECP2</span>
                    <span class="gene-box">SMN1</span>
                    <span class="gene-box">CFTR</span>
                    <span class="gene-box">DMD</span>
                    <span class="gene-box">FMR1</span>
                    <span class="gene-box">COL4A5</span>
                    <span class="gene-box">BRCA1/2</span>
                </div>

                <div class="stats-grid">
                    <div class="stat-card">
                        <div class="stat-number">25-50%</div>
                        <div class="stat-label">Diagnostic Yield for WES</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-number">~7,000</div>
                        <div class="stat-label">Known Rare Diseases</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-number">3-6 weeks</div>
                        <div class="stat-label">Typical TAT</div>
                    </div>
                </div>
            </div>

            <!-- Example 2: Cancer Precision Medicine -->
            <div class="example-card">
                <div class="example-title">
                    <span class="example-number">2</span>
                    Cancer Precision Medicine & Treatment Selection
                </div>
                
                <div class="example-description">
                    Tumor sequencing identifies somatic mutations, copy number variations, and gene fusions that drive cancer growth. This information guides targeted therapy selection, predicts treatment response, and monitors disease progression through liquid biopsies.
                </div>

                <div class="illustration-box">
                    <div class="workflow-diagram">
                        <div class="workflow-step">
                            <div style="font-size: 24px; margin-bottom: 8px;">ðŸ”¬</div>
                            <div style="font-weight: 600;">Tumor Biopsy</div>
                            <div style="font-size: 13px; color: #666;">Tissue/Blood</div>
                        </div>
                        <div class="workflow-arrow">â†’</div>
                        <div class="workflow-step">
                            <div style="font-size: 24px; margin-bottom: 8px;">ðŸ§¬</div>
                            <div style="font-weight: 600;">DNA/RNA</div>
                            <div style="font-size: 13px; color: #666;">Extraction</div>
                        </div>
                        <div class="workflow-arrow">â†’</div>
                        <div class="workflow-step">
                            <div style="font-size: 24px; margin-bottom: 8px;">ðŸ“Š</div>
                            <div style="font-weight: 600;">Panel Seq</div>
                            <div style="font-size: 13px; color: #666;">50-500 genes</div>
                        </div>
                        <div class="workflow-arrow">â†’</div>
                        <div class="workflow-step">
                            <div style="font-size: 24px; margin-bottom: 8px;">ðŸŽ¯</div>
                            <div style="font-weight: 600;">Actionable</div>
                            <div style="font-size: 13px; color: #666;">Variants</div>
                        </div>
                        <div class="workflow-arrow">â†’</div>
                        <div class="workflow-step">
                            <div style="font-size: 24px; margin-bottom: 8px;">ðŸ’Š</div>
                            <div style="font-weight: 600;">Therapy</div>
                            <div style="font-size: 13px; color: #666;">Selection</div>
                        </div>
                    </div>
                </div>

                <div class="case-example">
                    <div class="case-title">ðŸ“Œ Clinical Case Example</div>
                    <strong>Patient:</strong> 58-year-old woman with stage IV non-small cell lung cancer (NSCLC)<br>
                    <strong>Tumor sequencing:</strong> Comprehensive cancer panel (468 genes)<br>
                    <strong>Key findings:</strong> EGFR exon 19 deletion, TMB-high (15 mutations/Mb)<br>
                    <strong>Treatment:</strong> First-line EGFR TKI (osimertinib) â†’ significant tumor reduction<br>
                    <strong>Monitoring:</strong> ctDNA liquid biopsy for resistance mutations (T790M)
                </div>

                <div class="variant-display">
&gt; Actionable Variants Detected:<br>
EGFR: c.2235_2249del15 (p.Leu747_Thr751del) - PATHOGENIC<br>
  â†³ FDA-approved therapy: Osimertinib, Erlotinib, Gefitinib<br>
  â†³ Evidence level: 1A (NCCN Guidelines)<br><br>
PD-L1 expression: 60% TPS<br>
  â†³ Eligible for pembrolizumab combination therapy<br><br>
TMB: 15.2 mutations/Mb (TMB-High)<br>
  â†³ Potential benefit from immunotherapy
                </div>

                <div class="detail-box">
                    <div class="detail-title">Common Targetable Alterations by Cancer Type</div>
                    <strong>Lung Cancer:</strong> EGFR, ALK, ROS1, BRAF, MET, KRAS G12C<br>
                    <strong>Breast Cancer:</strong> HER2, PIK3CA, ESR1, BRCA1/2, PALB2<br>
                    <strong>Colorectal:</strong> KRAS, NRAS, BRAF V600E, MSI-H, TMB-H<br>
                    <strong>Melanoma:</strong> BRAF V600E/K, NRAS, KIT, NF1<br>
                    <strong>Ovarian:</strong> BRCA1/2, HRD score, CCNE1 amplification
                </div>

                <div class="stats-grid">
                    <div class="stat-card">
                        <div class="stat-number">30-40%</div>
                        <div class="stat-label">Patients with Actionable Mutations</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-number">50-75%</div>
                        <div class="stat-label">Improved Response with Targeted Therapy</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-number">7-10 days</div>
                        <div class="stat-label">Typical TAT</div>
                    </div>
                </div>
            </div>

            <!-- Example 3: Pharmacogenomics -->
            <div class="example-card">
                <div class="example-title">
                    <span class="example-number">3</span>
                    Pharmacogenomics - Drug Response Prediction
                </div>
                
                <div class="example-description">
                    Pharmacogenomic testing analyzes genetic variants in genes encoding drug-metabolizing enzymes, transporters, and drug targets. This enables personalized medication selection and dosing to maximize efficacy and minimize adverse reactions.
                </div>

                <div class="illustration-box">
                    <div style="margin-bottom: 20px;">
                        <div style="font-size: 20px; font-weight: 600; color: #1E64C8; margin-bottom: 15px;">CYP2D6 Enzyme Activity Spectrum</div>
                        <div style="display: flex; justify-content: space-between; align-items: flex-end; height: 120px;">
                            <div style="text-align: center; flex: 1;">
                                <div style="background: #e74c3c; height: 40px; margin: 0 5px; border-radius: 4px 4px 0 0;"></div>
                                <div style="font-size: 13px; margin-top: 8px; font-weight: 600;">Poor<br>Metabolizer</div>
                                <div style="font-size: 12px; color: #666;">No activity</div>
                            </div>
                            <div style="text-align: center; flex: 1;">
                                <div style="background: #e67e22; height: 70px; margin: 0 5px; border-radius: 4px 4px 0 0;"></div>
                                <div style="font-size: 13px; margin-top: 8px; font-weight: 600;">Intermediate<br>Metabolizer</div>
                                <div style="font-size: 12px; color: #666;">Reduced</div>
                            </div>
                            <div style="text-align: center; flex: 1;">
                                <div style="background: #27ae60; height: 100px; margin: 0 5px; border-radius: 4px 4px 0 0;"></div>
                                <div style="font-size: 13px; margin-top: 8px; font-weight: 600;">Normal<br>Metabolizer</div>
                                <div style="font-size: 12px; color: #666;">Normal</div>
                            </div>
                            <div style="text-align: center; flex: 1;">
                                <div style="background: #f39c12; height: 90px; margin: 0 5px; border-radius: 4px 4px 0 0;"></div>
                                <div style="font-size: 13px; margin-top: 8px; font-weight: 600;">Rapid<br>Metabolizer</div>
                                <div style="font-size: 12px; color: #666;">Increased</div>
                            </div>
                            <div style="text-align: center; flex: 1;">
                                <div style="background: #e74c3c; height: 110px; margin: 0 5px; border-radius: 4px 4px 0 0;"></div>
                                <div style="font-size: 13px; margin-top: 8px; font-weight: 600;">Ultra-Rapid<br>Metabolizer</div>
                                <div style="font-size: 12px; color: #666;">Very high</div>
                            </div>
                        </div>
                    </div>
                </div>

                <div class="case-example">
                    <div class="case-title">ðŸ“Œ Clinical Case Example</div>
                    <strong>Patient:</strong> 45-year-old woman starting antidepressant therapy<br>
                    <strong>PGx Testing:</strong> CYP2D6, CYP2C19, CYP3A4/5, SLCO1B1<br>
                    <strong>Results:</strong><br>
                    â€¢ CYP2D6: *4/*4 (Poor metabolizer)<br>
                    â€¢ CYP2C19: *1/*17 (Rapid metabolizer)<br>
                    <strong>Interpretation:</strong><br>
                    â€¢ Avoid codeine (no therapeutic effect), tramadol<br>
                    â€¢ Reduce dose of metoprolol by 75%<br>
                    â€¢ Standard dose clopidogrel appropriate<br>
                    <strong>Drug Selection:</strong> Venlafaxine selected over paroxetine (CYP2D6 substrate)
                </div>

                <div class="detail-box">
                    <div class="detail-title">Key Pharmacogenes and Associated Drugs</div>
                    <div style="display: grid; grid-template-columns: 1fr 2fr; gap: 10px; margin-top: 10px;">
                        <div style="font-weight: 600;">CYP2D6:</div>
                        <div>Codeine, tramadol, metoprolol, paroxetine, tamoxifen</div>
                        <div style="font-weight: 600;">CYP2C19:</div>
                        <div>Clopidogrel, omeprazole, escitalopram, voriconazole</div>
                        <div style="font-weight: 600;">CYP2C9:</div>
                        <div>Warfarin, phenytoin, NSAIDs, losartan</div>
                        <div style="font-weight: 600;">TPMT:</div>
                        <div>Azathioprine, mercaptopurine, thioguanine</div>
                        <div style="font-weight: 600;">SLCO1B1:</div>
                        <div>Statins (simvastatin, atorvastatin)</div>
                        <div style="font-weight: 600;">DPYD:</div>
                        <div>5-fluorouracil, capecitabine (cancer therapy)</div>
                        <div style="font-weight: 600;">VKORC1:</div>
                        <div>Warfarin dosing</div>
                        <div style="font-weight: 600;">HLA-B*57:01:</div>
                        <div>Abacavir hypersensitivity</div>
                    </div>
                </div>

                <div class="stats-grid">
                    <div class="stat-card">
                        <div class="stat-number">95%</div>
                        <div class="stat-label">Population with Actionable PGx Variant</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-number">30%</div>
                        <div class="stat-label">ADR Prevention Rate</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-number">270+</div>
                        <div class="stat-label">FDA PGx Drug Labels</div>
                    </div>
                </div>
            </div>

            <!-- Example 4: Prenatal/Newborn Screening -->
            <div class="example-card">
                <div class="example-title">
                    <span class="example-number">4</span>
                    Prenatal and Newborn Screening
                </div>
                
                <div class="example-description">
                    Non-invasive prenatal testing (NIPT) analyzes cell-free fetal DNA in maternal blood to screen for chromosomal abnormalities. Newborn sequencing enables early detection and treatment of genetic disorders before symptoms appear.
                </div>

                <div class="illustration-box">
                    <div style="margin-bottom: 20px;">
                        <div style="font-size: 20px; font-weight: 600; color: #1E64C8; margin-bottom: 15px;">Prenatal Testing Timeline</div>
                        <div style="display: flex; align-items: center; justify-content: space-around;">
                            <div style="text-align: center;">
                                <div style="background: #e8f4f8; border: 2px solid #1E64C8; border-radius: 50%; width: 80px; height: 80px; display: flex; align-items: center; justify-content: center; margin: 0 auto 10px; font-size: 24px; font-weight: 700; color: #1E64C8;">10+</div>
                                <div style="font-weight: 600;">NIPT</div>
                                <div style="font-size: 13px; color: #666;">Weeks</div>
                            </div>
                            <div style="font-size: 24px; color: #1E64C8;">â†’</div>
                            <div style="text-align: center;">
                                <div style="background: #e8f4f8; border: 2px solid #1E64C8; border-radius: 50%; width: 80px; height: 80px; display: flex; align-items: center; justify-content: center; margin: 0 auto 10px; font-size: 24px; font-weight: 700; color: #1E64C8;">11-14</div>
                                <div style="font-weight: 600;">CVS</div>
                                <div style="font-size: 13px; color: #666;">Weeks</div>
                            </div>
                            <div style="font-size: 24px; color: #1E64C8;">â†’</div>
                            <div style="text-align: center;">
                                <div style="background: #e8f4f8; border: 2px solid #1E64C8; border-radius: 50%; width: 80px; height: 80px; display: flex; align-items: center; justify-content: center; margin: 0 auto 10px; font-size: 24px; font-weight: 700; color: #1E64C8;">15-20</div>
                                <div style="font-weight: 600;">Amnio</div>
                                <div style="font-size: 13px; color: #666;">Weeks</div>
                            </div>
                            <div style="font-size: 24px; color: #1E64C8;">â†’</div>
                            <div style="text-align: center;">
                                <div style="background: #e8f4f8; border: 2px solid #1E64C8; border-radius: 50%; width: 80px; height: 80px; display: flex; align-items: center; justify-content: center; margin: 0 auto 10px; font-size: 24px; font-weight: 700; color: #1E64C8;">24-48h</div>
                                <div style="font-weight: 600;">NBS</div>
                                <div style="font-size: 13px; color: #666;">After birth</div>
                            </div>
                        </div>
                    </div>
                </div>

                <div class="case-example">
                    <div class="case-title">ðŸ“Œ Clinical Case Example - NIPT</div>
                    <strong>Patient:</strong> 38-year-old pregnant woman, 12 weeks gestation<br>
                    <strong>Test:</strong> cfDNA NIPT from maternal blood<br>
                    <strong>Results:</strong> Elevated risk for Trisomy 21 (Down syndrome)<br>
                    <strong>Follow-up:</strong> Diagnostic amniocentesis confirmed T21<br>
                    <strong>Outcome:</strong> Genetic counseling, preparation for specialized care<br><br>
                    <strong>Detection rates:</strong> T21 (99%), T18 (97%), T13 (91%)
                </div>

                <div class="case-example">
                    <div class="case-title">ðŸ“Œ Clinical Case Example - NBS</div>
                    <strong>Patient:</strong> 48-hour-old newborn<br>
                    <strong>Screen:</strong> State mandated newborn screening panel<br>
                    <strong>Positive result:</strong> Elevated C8 acylcarnitine<br>
                    <strong>Diagnosis:</strong> Medium-chain acyl-CoA dehydrogenase deficiency (MCADD)<br>
                    <strong>Treatment initiated:</strong> Avoid fasting, high-carb diet, emergency protocol<br>
                    <strong>Impact:</strong> Prevention of potentially fatal metabolic crisis
                </div>

                <div class="detail-box">
                    <div class="detail-title">Conditions Screened in Newborns (US Recommended Core Panel)</div>
                    <strong>Organic Acid Disorders:</strong> Propionic acidemia, Methylmalonic acidemia, Isovaleric acidemia<br>
                    <strong>Fatty Acid Oxidation:</strong> MCADD, VLCADD, LCHAD deficiency<br>
                    <strong>Amino Acid Disorders:</strong> PKU, Maple syrup urine disease, Homocystinuria<br>
                    <strong>Hemoglobinopathies:</strong> Sickle cell disease, Beta-thalassemia<br>
                    <strong>Endocrine:</strong> Congenital hypothyroidism, CAH<br>
                    <strong>Other:</strong> Biotinidase deficiency, Galactosemia, Cystic fibrosis, SCID
                </div>

                <div class="stats-grid">
                    <div class="stat-card">
                        <div class="stat-number">99%</div>
                        <div class="stat-label">NIPT Sensitivity for T21</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-number">35+</div>
                        <div class="stat-label">NBS Core Conditions</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-number">1 in 300</div>
                        <div class="stat-label">NBS Detection Rate</div>
                    </div>
                </div>
            </div>

            <!-- Example 5: Infectious Disease -->
            <div class="example-card">
                <div class="example-title">
                    <span class="example-number">5</span>
                    Infectious Disease Identification
                </div>
                
                <div class="example-description">
                    Metagenomic Next-Generation Sequencing (mNGS) enables unbiased detection of all microbial DNA/RNA in clinical samples. This approach identifies pathogens without prior knowledge or culture, crucial for diagnosing unusual or fastidious infections.
                </div>

                <div class="illustration-box">
                    <div class="workflow-diagram">
                        <div class="workflow-step">
                            <div style="font-size: 24px; margin-bottom: 8px;">ðŸ§ª</div>
                            <div style="font-weight: 600;">Sample</div>
                            <div style="font-size: 13px; color: #666;">CSF/Blood/BAL</div>
                        </div>
                        <div class="workflow-arrow">â†’</div>
                        <div class="workflow-step">
                            <div style="font-size: 24px; margin-bottom: 8px;">ðŸ”¬</div>
                            <div style="font-weight: 600;">Extract</div>
                            <div style="font-size: 13px; color: #666;">DNA/RNA</div>
                        </div>
                        <div class="workflow-arrow">â†’</div>
                        <div class="workflow-step">
                            <div style="font-size: 24px; margin-bottom: 8px;">ðŸ§¬</div>
                            <div style="font-weight: 600;">mNGS</div>
                            <div style="font-size: 13px; color: #666;">Sequence all</div>
                        </div>
                        <div class="workflow-arrow">â†’</div>
                        <div class="workflow-step">
                            <div style="font-size: 24px; margin-bottom: 8px;">ðŸ’»</div>
                            <div style="font-weight: 600;">Align</div>
                            <div style="font-size: 13px; color: #666;">Pathogen DB</div>
                        </div>
                        <div class="workflow-arrow">â†’</div>
                        <div class="workflow-step">
                            <div style="font-size: 24px; margin-bottom: 8px;">ðŸ¦ </div>
                            <div style="font-weight: 600;">Identify</div>
                            <div style="font-size: 13px; color: #666;">Pathogen</div>
                        </div>
                    </div>
                </div>

                <div class="case-example">
                    <div class="case-title">ðŸ“Œ Clinical Case Example</div>
                    <strong>Patient:</strong> 14-year-old boy with encephalitis, seizures, altered consciousness<br>
                    <strong>Initial testing:</strong> Bacterial culture, viral PCR panel - all negative<br>
                    <strong>mNGS (CSF):</strong> Performed after 1 week of empiric treatment<br>
                    <strong>Results:</strong> <em>Balamuthia mandrillaris</em> detected (1,237 reads mapped)<br>
                    <strong>Diagnosis:</strong> Rare amoebic encephalitis<br>
                    <strong>Treatment:</strong> Switched to appropriate anti-parasitic therapy<br>
                    <strong>TAT:</strong> 48 hours from sample to result
                </div>

                <div class="variant-display">
&gt; mNGS Report Summary:<br>
Total reads: 28,456,891<br>
Human reads: 28,442,108 (99.95%)<br>
Non-human reads: 14,783 (0.05%)<br><br>
PATHOGEN DETECTED:<br>
Organism: Balamuthia mandrillaris<br>
Reads mapped: 1,237<br>
Genome coverage: 12.4%<br>
Confidence: HIGH<br>
Clinical significance: PATHOGENIC - causes GAE
                </div>

                <div class="detail-box">
                    <div class="detail-title">Clinical Applications of Infectious Disease Sequencing</div>
                    <strong>Meningitis/Encephalitis:</strong> Rapid pathogen ID when culture-negative<br>
                    <strong>Sepsis:</strong> Blood culture-independent pathogen detection<br>
                    <strong>Pneumonia:</strong> Identification of atypical/fastidious organisms<br>
                    <strong>Immunocompromised:</strong> Detection of opportunistic infections<br>
                    <strong>Outbreak investigation:</strong> Strain typing and transmission tracking<br>
                    <strong>Antimicrobial resistance:</strong> Detection of resistance genes<br>
                    <strong>HIV/HCV:</strong> Viral load monitoring, resistance mutations<br>
                    <strong>TB:</strong> <em>M. tuberculosis</em> detection and drug resistance profiling
                </div>

                <div class="detail-box">
                    <div class="detail-title">Advantages over Traditional Methods</div>
                    âœ“ Culture-independent (detects non-cultivable organisms)<br>
                    âœ“ Unbiased (no prior hypothesis needed)<br>
                    âœ“ Rapid results (24-48 hours vs days/weeks for culture)<br>
                    âœ“ Detects co-infections<br>
                    âœ“ Identifies novel/unexpected pathogens<br>
                    âœ“ Simultaneous resistance gene detection<br>
                    âœ“ Works with small sample volumes
                </div>

                <div class="stats-grid">
                    <div class="stat-card">
                        <div class="stat-number">24-48h</div>
                        <div class="stat-label">mNGS Turnaround Time</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-number">40-70%</div>
                        <div class="stat-label">Diagnostic Yield in CNS Infections</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-number">1000s</div>
                        <div class="stat-label">Detectable Pathogens</div>
                    </div>
                </div>
            </div>

        </div>

        <!-- Final Summary Box -->
        <div class="highlight-box" style="margin-top: 40px;">
            <div class="highlight-text" style="font-size: 16px;">
                Clinical sequencing has transformed medicine by enabling precision diagnosis and treatment.<br>
                Each application requires rigorous validation, quality control, and multidisciplinary interpretation<br>
                to translate genomic data into actionable clinical decisions.
            </div>
        </div>
    </div>
</body>
</html>